Cargando…

Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening

BACKGROUND: Pulmonary vasodilators in general and prostacyclin analogues in particular have improved the outcome of patients with pulmonary arterial hypertension (PAH). Endothelial dysfunction is a key feature of PAH and we previously described that circulating endothelial cell (CEC) level could be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levy, Marilyne, Bonnet, Damien, Mauge, Laetitia, Celermajer, David S., Gaussem, Pascale, Smadja, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677895/ https://www.ncbi.nlm.nih.gov/pubmed/23762293 http://dx.doi.org/10.1371/journal.pone.0065114

Ejemplares similares

Correction: Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening
por: Levy, Marilyne, et al.
Publicado: (2014)

Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension
por: Smadja, David M., et al.
Publicado: (2010)

Potts anastomosis in children with severe pulmonary arterial hypertension and atrial septal defect
por: Capel, Alice, et al.
Publicado: (2020)

Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension
por: Grynblat, Julien, et al.
Publicado: (2023)

Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells
por: Smadja, David M, et al.
Publicado: (2008)

Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin α(6)
por: Smadja, David M, et al.
Publicado: (2007)

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality
por: Philippe, Aurélien, et al.
Publicado: (2021)

Circulating miRNAs as Potential Marker for Pulmonary Hypertension
por: Wei, Chuanyu, et al.
Publicado: (2013)

Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes
por: Ratwatte, Seshika, et al.
Publicado: (2023)

RETRACTED: Right to left ventricular volume ratio: A novel marker of disease severity in chronic thromboembolic pulmonary hypertension()
por: Jaijee, Shareen, et al.
Publicado: (2013)

Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension
por: Haddad, Raymond N., et al.
Publicado: (2022)

Role of circulating endothelial cells in assessing the severity of systemic sclerosis and predicting its clinical worsening
por: Di Martino, Maria Luisa, et al.
Publicado: (2021)

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023)

Multi‐Beat Right Ventricular‐Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension
por: Hsu, Steven, et al.
Publicado: (2020)

Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular Afterload
por: Goudot, Guillaume, et al.
Publicado: (2020)

Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound
por: Lau, Edmund M. T., et al.
Publicado: (2012)

Worsened hypertension control induced by aripiprazole
por: Yasui-Furukori, Norio, et al.
Publicado: (2013)

Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
por: Khider, Lina, et al.
Publicado: (2022)

Haemodynamic definitions and updated clinical classification of pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2019)

Disturbed blood flow worsens endothelial dysfunction in moderate-severe chronic obstructive pulmonary disease
por: Barak, Otto F., et al.
Publicado: (2017)

Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Alabed, Samer, et al.
Publicado: (2021)

Endoglin Is an Endothelial Housekeeper against Inflammation: Insight in ECFC-Related Permeability through LIMK/Cofilin Pathway
por: Rossi, Elisa, et al.
Publicado: (2021)

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients
por: Smadja, David M., et al.
Publicado: (2020)

Pulmonary Circulation with Chronic Thromboembolic Pulmonary Hypertension
por: Fukamachi, Daisuke, et al.
Publicado: (2022)

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
por: Freed, Benjamin H, et al.
Publicado: (2012)

Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
por: Fujita, Naoto, et al.
Publicado: (2018)

Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2019)

Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series)
por: Kuebler, Wolfgang M., et al.
Publicado: (2018)

Control of the Adaptive Immune Response by Tumor Vasculature
por: Mauge, Laetitia, et al.
Publicado: (2014)

Is there a learning effect when the 6-minute walk test is repeated in people with suspected pulmonary hypertension?
por: Spencer, Lissa, et al.
Publicado: (2018)

Flow-Mediated Dilation, a Marker of Endothelial Cell Dysfunction, in Patients with Pulmonary Hypertension
por: Mirdamadi, Ahmad, et al.
Publicado: (2021)

Pregnancy-Induced Hypertension is Accompanied by Decreased Number of Circulating Endothelial Cells and Circulating Endothelial Progenitor Cells
por: Heimrath, Jerzy, et al.
Publicado: (2014)

Platypnea‐Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease
por: Othman, Farrah, et al.
Publicado: (2022)

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
por: Seegobin, Karan, et al.
Publicado: (2017)

Impact of Exercise-Induced Pulmonary Hypertension on Right Ventricular Function and on Worsening of Cardiovascular Risk in HIV Patients
por: Madonna, Rosalinda, et al.
Publicado: (2022)

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending‐dose study
por: Small, David, et al.
Publicado: (2019)

Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention
por: Grunig, Gabriele, et al.
Publicado: (2018)

Non-invasive Multimodality Cardiovascular Imaging of the Right Heart and Pulmonary Circulation in Pulmonary Hypertension
por: Hur, David J., et al.
Publicado: (2019)

Does smoking cessation with varenicline worsen vascular endothelial function?
por: Umeda, Akira, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uf47gdb3dk6bpl90vdk91htrk0